MKI67 and neoplasm: The exposure to the FRS2αi effectively reduced the proliferation of tumor‐promoting CAFs that were in physical contact with the tumor cells, resulting in the disruption of viable tumor‐stroma interactions, and decreasing the proliferation of the tumor organotypic structures as indicated by the significant reduction of Ki67.